Get the content you want anytime you want.
REGISTER NOW | SIGN IN
<< View All Contributors
Saskia v. Popescu, MPH, MA, CIC, is a hospital epidemiologist and infection preventionist with Phoenix Children's Hospital. During her work as an infection preventionist she performed surveillance for infectious diseases, preparedness, and Ebola-response practices. She is currently a PhD candidate in Biodefense at George Mason University where her research focuses on the role of infection prevention in facilitating global health security efforts. She is certified in Infection Control.

CDC Quarantines Potentially Defective Equipment

AUG 28, 2017 | SASKIA V. POPESCU
A recent 60 Minutes report is drawing attention to potentially defective equipment stockpiled by the Centers for Disease Control and Prevention (CDC). Although this special first aired in 2016, it was re-run the week of August 8, 2017, which brought forth the question of, “what is being done?”

The special focused on personal protective equipment (PPE) that was being stockpiled by the CDC for use against future outbreaks or public health emergencies, such as treating an influx of Ebola patients during an outbreak. The 60 Minutes investigative team filed a Freedom of Information Act request to obtain documents regarding MicroCool gowns that are part of the US Strategic National Stockpile (SNS). The SNS, according to the CDC, is the “nation’s largest supply of potentially life-saving pharmaceuticals and medical supplies for use in a public health emergency severe enough to cause local supplies to run out.”

The filing of the Freedom of Information Act request is especially prudent as a group of hospitals were recently awarded $454 million in damages from PPE manufacturers Kimberly-Clark and Halyard Health (formerly a division of Kimberly-Clark) after a jury found they were liable for fraud and defects within the MicroCool gowns. The 60 Minutes team reached out to Halyard. Their chief operating officer Chris Lowery responded that, “We get less than one complaint for every million gowns sold," Lowery said. "And...we've never received even one report of a healthcare professional contracting an infection as a result of a flaw in our product.” Halyard and Kimberly-Clark are reportedly challenging the court’s decision. 

In response to this report, the court case, and the Freedom of Information Act request, the CDC has pulled the MicroCool gowns from the SNS and has “quarantined” them to ensure they are not used. (You can check out the MicroCool gowns here.)

The MicroCool gowns are sold on the notion that they will provide protection while keeping the person wearing it more comfortable (surgical gowns can easily make the wearer hot). The gowns tout that they passed the ASTM 1671 Standard Test Method, which means they are protective against the penetration of blood-borne pathogens. The reason for the concern, and the subsequent law suits, is that the gowns reportedly leak, and this can expose healthcare workers to blood and other potentially infectious materials (ie, urine, feces, etc.).

The 60 Minutes team noted that the MicroCool gowns were being advertised as meeting Association for the Advancement of Medical Instrumentation (AAMI) Level 4 standards, which means they are the highest level in terms of being impermeable and preventing blood from penetrating the gown to potentially expose the healthcare worker. Interestingly, if you wander around the Halyard webpage on surgical attire, the MicroCool gown no longer has this standard, although their other gowns do. And, it wasn’t that long ago that Kimberly-Clark Health was given FDA approval to market the MicroCool gowns as meeting AAMI Level 4 Standards.

Because hospital Ebola PPE carts have mostly been neglected since the outbreak ended, this report and the court finding highlight the challenges of preparedness. Surgical gowns are an extremely important aspect of infection control and faulty or defective gowns can exponentially put healthcare workers at risk. During public health emergencies, such as outbreaks of diseases that might require enhanced precautions, the availability of necessary PPE will be strained and the last thing we should be worrying about at that time is their efficacy and safety. 
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.
FEATURED
NIAID researchers make an unexpected discovery when examining how a cellular enzyme complex regulates herpesvirus; inhibiting the enzyme suppressed viral infection.
More from Saskia v. Popescu
Biological threats are becoming increasingly diverse and we must consider this when responding within the healthcare environment.
PUBLISHED: Tue September 19 2017
Gastroenteritis outbreak response requires effective environmental sampling and, here, we break down a seemingly promising new strategy.
PUBLISHED: Mon September 11 2017
Diagnostic methods make all the difference in efforts against antimicrobial resistance.
PUBLISHED: Thu September 07 2017
To paraphrase Anthelme Brillat-Savarin, “we are what we eat”—Especially when it comes to antimicrobials and food-producing animals.
PUBLISHED: Tue August 29 2017
x